Literature DB >> 18763302

Arylamine N-acetyltransferases: a new inhibitor of apoptosis in HepG2 cells.

Yu-bin Ji1, Shi-yong Gao.   

Abstract

OBJECTIVE: To explore how arylamine N-acetyltransferases (NATs) is related to cell apoptosis.
METHODS: NAT activity in apoptotic HepG2 cells was measured using high performance liquid chromatography (HPLC); the apoptosis rate of HepG2 cells acted upon by an NAT inhibitor was measured using flow cytometry.
RESULTS: NAT activity was lowered in apoptotic HepG2 cells; apoptosis rate induced by camptothecin (CAM) increased after inhibition of NAT activity in HepG2 cells.
CONCLUSION: NAT can inhibit apoptosis in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763302      PMCID: PMC2528884          DOI: 10.1631/jzus.B0820090

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  15 in total

1.  Structure of arylamine N-acetyltransferase reveals a catalytic triad.

Authors:  J C Sinclair; J Sandy; R Delgoda; E Sim; M E Noble
Journal:  Nat Struct Biol       Date:  2000-07

2.  Cysteine protease mcII-Pa executes programmed cell death during plant embryogenesis.

Authors:  Peter V Bozhkov; Maria F Suarez; Lada H Filonova; Geoffrey Daniel; Andrey A Zamyatnin; Salvador Rodriguez-Nieto; Boris Zhivotovsky; Andrei Smertenko
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-23       Impact factor: 11.205

Review 3.  Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines.

Authors:  C M King; S J Land; R F Jones; M Debiec-Rychter; M S Lee; C Y Wang
Journal:  Mutat Res       Date:  1997-05-12       Impact factor: 2.433

Review 4.  Revised definition of substrate binding sites of papain-like cysteine proteases.

Authors:  D Turk; G Guncar; M Podobnik; B Turk
Journal:  Biol Chem       Date:  1998-02       Impact factor: 3.915

Review 5.  N-acetylation pharmacogenetics.

Authors:  W W Weber; D W Hein
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

6.  Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases.

Authors:  D W Hein; T D Rustan; R J Ferguson; M A Doll; K Gray
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

7.  Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

Authors:  D W Hein; M A Doll; T D Rustan; K Gray; Y Feng; R J Ferguson; D M Grant
Journal:  Carcinogenesis       Date:  1993-08       Impact factor: 4.944

Review 8.  Acetyltransferases and susceptibility to chemicals.

Authors:  D W Hein; T D Rustan; M A Doll; K D Bucher; R J Ferguson; Y Feng; E J Furman; K Gray
Journal:  Toxicol Lett       Date:  1992-12       Impact factor: 4.372

9.  Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation.

Authors:  Guan-yu Wang; Jia-wei Zhang; Qing-hua Lü; Rong-zhen Xu; Qing-hua Dong
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

10.  Anticancer effect of two diterpenoid compounds isolated from Annona glabra Linn.

Authors:  Yong-hong Zhang; Hai-yan Peng; Guo-hao Xia; Ming-yan Wang; Ying Han
Journal:  Acta Pharmacol Sin       Date:  2004-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.